U.S. Tobacco Stock News

FDA approves Jakafi XR extended-release tablets for myelofibrosis, polycythemia vera and graft-versus-host disease. Jakafi XR offers a once-daily dosing option that differs from existing formulations of ruxolitinib. The approval expands Incyte's Jakafi franchise and broadens its treatment toolkit across several serious blood and immune conditions. For investors watching NasdaqGS:INCY, this latest approval sits at the heart of the company’s core focus in hematology and oncology. Jakafi has...

Mattel has completed the acquisition of mobile game studio Mattel163, taking full control of its digital gaming business. The company is rolling out the new Mattel Brick Shop, a construction toy concept positioned to compete more directly with LEGO. Mattel is also deepening its entertainment efforts, tying its brands more closely to film and content projects. NasdaqGS:MAT is trading at $14.72, with the stock down 26.5% year to date and 30.3% over five years. In this context, the decision to...

In March 2026, MAC Cosmetics’ first-ever launch at Sephora, including Sephora at Kohl’s locations, quickly made it the number-five makeup brand there in its first month, with strong performance in lip products. An unusually high share of shoppers were entirely new to MAC and Sephora, highlighting how the partnership is expanding Kohl’s beauty reach and drawing incremental traffic. We’ll now explore how MAC’s strong customer acquisition at Sephora at Kohl’s may influence the company’s...

Excelerate Energy, Inc. recently declared a quarterly cash dividend of US$0.08 per share on its Class A common stock for the quarter ended March 31, 2026, payable on June 4, 2026 to stockholders of record as of May 20, 2026. This routine dividend affirmation comes just ahead of Excelerate Energy’s upcoming Q1 earnings release, putting income stability and operating performance under closer investor scrutiny. We’ll now examine how Excelerate’s latest dividend declaration, alongside the...

In recent weeks, LegalZoom.com drew fresh attention by offering free trademark legal support to Taylor Swift and other public figures to counter AI-driven impersonations, while investors also looked ahead to its upcoming earnings release. This high-profile move highlights how LegalZoom is positioning its brand at the center of emerging AI-related identity and intellectual property concerns. We’ll now examine how LegalZoom’s high-profile AI impersonation support offer could influence its...

Johnson & Johnson's Ottava Robotic Surgical System has reported its first successful clinical outcomes in complex gastric bypass procedures. The system met primary safety and performance endpoints in a prospective study, with no conversions reported. The company has submitted an FDA De Novo application for Ottava to support wider use in gastrointestinal surgery. For investors following NYSE:JNJ, this update adds a fresh element to the story beyond the core pharmaceutical portfolio. The...

In recent weeks, Critical Metals Corp. secured Greenland government approval to acquire a 70% stake in 60° North Greenland ApS and closed the transfer that lifted its ownership of the Tanbreez Mining Greenland rare earth project to 92.5%, while progressing plans to acquire the remaining 7.5% via European Lithium. These moves, alongside advancing pilot plant work at Tanbreez and building a Romanian mine-to-magnet JV focused on NATO and EU supply chains, materially deepen Critical Metals’...

MSA Safety (MSA) has just opened Q1 2026 earnings season with a run of solid headline figures, capped by Q4 2025 revenue of US$510.9 million and basic EPS of US$2.22. Over recent quarters the company has seen revenue move from US$499.7 million in Q4 2024 to US$421.3 million in Q1 2025 and then back to US$510.9 million in Q4 2025, while quarterly EPS ranged between roughly US$1.51 and US$2.23, setting up a results story where margins and profit quality are front and center for investors. See...

Wondering if Allison Transmission Holdings at around US$127 per share is still good value, or if most of the easy upside is already behind it. The stock has seen a 2% decline over the last 7 days, but is up 8.8% over 30 days, 28.7% year to date, 32.7% over 1 year and more than 7x over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Allison Transmission Holdings as a long term compounder for investors who held through the last several...

Agilent Technologies (A) is drawing fresh attention after the FDA approved its PD-L1 IHC 22C3 pharmDx test as the only companion diagnostic for certain esophageal and gastroesophageal junction cancers treated with pembrolizumab. See our latest analysis for Agilent Technologies. The FDA companion diagnostic approval arrives alongside a 4.77% 1 day share price return and a 2.32% 7 day share price return. However, the 90 day share price return of 11.62% and year to date share price return of...

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...

If you have been wondering whether PG&E at US$16.33 is priced attractively or not, the key question is how that share price lines up against the company’s underlying value. The stock has been relatively steady over the last year with a 0.4% return year to date and a 3.3% decline over 12 months. Over the last 30 days it declined 8.1%, following a modest 0.4% gain over the past week. Recent news around PG&E has continued to focus on its role as a major California electric utility, including...

Selective Insurance Group (SIGI) has drawn fresh attention after first quarter 2026 results combined higher reported revenue with lower net income, along with affirmed common and preferred dividends and an update on its ongoing share repurchase activity. See our latest analysis for Selective Insurance Group. At a share price of US$82.15, SIGI has seen a 6.8% 1 month share price return but a 7.8% 3 month share price decline, while 1 year total shareholder return is a 6.0% loss. This suggests...

Carpenter Technology (CRS) raised its fiscal 2026 operating income guidance by at least 33% and paired that with third quarter results showing higher sales and net income. Together, these developments can quickly reshape how you think about this stock. See our latest analysis for Carpenter Technology. The raised guidance and stronger recent earnings have come alongside a 90 day share price return of 33.15% and a 1 year total shareholder return of 114.97%. This points to strong momentum that...

In late April 2026, The Hershey Company reported first-quarter sales of US$3,104.17 million and net income of US$435.11 million, declared quarterly dividends on its common and Class B shares, and reaffirmed its 2026 earnings guidance. A separate collaboration announced by Ryl Tea introduced zero-sugar Jolly Rancher-branded iced teas, highlighting how Hershey is extending its confectionery brands into new beverage formats. Now we’ll consider how Hershey’s reaffirmed full-year earnings...

In April 2026, Coursera reported first-quarter 2026 revenue of US$195.7 million, up from US$179.3 million a year earlier, while its net loss widened to US$20.5 million and loss per share increased to US$0.12. The company paired this with cautious commentary on its enterprise business, yet still projected second-quarter revenue of US$196 million to US$200 million and reaffirmed full-year 2026 revenue guidance of US$805 million to US$815 million, highlighting both growth and execution...

Arrowhead Pharmaceuticals announced that Australia’s Therapeutic Goods Administration has approved REDEMPLO (plozasiran), a first-in-class siRNA therapy self-administered quarterly, as an adjunct to diet for adults with familial chylomicronemia syndrome whose triglyceride levels remain uncontrolled on standard treatments. This decision makes REDEMPLO the first and only approved FCS therapy in Australia, extending Arrowhead’s rare lipid disorder footprint following prior authorizations in the...

Suncrete (NasdaqGM:RMIX) has appointed Charles Owens and Noreen Skelly as independent directors to its Board. Both Owens and Skelly have also joined the Audit Committee, with Skelly serving as Chair. The appointments expand the Board and Audit Committee with additional construction and banking sector expertise. Suncrete, trading at around $15.4, has seen its share price move 38.9% over the past 30 days and 35.1% year to date, with a 39.1% return over the past year and a 2.7% decline over...

Emerging discounting on core On Holding products at key retailers and outlets has raised fresh questions about the strength of the NYSE:ONON premium brand. Channel checks highlight margin pressure in the wholesale channel, challenging recent messaging around full price discipline and margin expansion. The news follows the return of the co founders as co CEOs and arrives as investors reassess growth and profitability expectations. On Holding, trading at $34.59 under ticker NYSE:ONON, is...

Wondering whether American Express stock is still offering fair value at current levels, or if expectations have run ahead of reality. The stock closed at US$315.95, with returns of 0.0% over 7 days, 5.3% over 30 days, a 15.2% decline year to date, and 15.9% over the last year, so recent moves have been mixed across different timeframes. Recent commentary around American Express has focused on its role as a major card issuer and payments network, and how changing consumer spending patterns...

Tanger (SKT) opened Q1 2026 with total revenue of US$150.4 million and basic EPS of US$0.25, alongside Funds From Operations of US$70.4 million. These results put fresh numbers behind the recent share price of US$36.20. Over the past year, the company’s total revenue moved from US$137.8 million in Q1 2025 to US$150.4 million in Q1 2026, while basic EPS shifted from US$0.17 to US$0.25. This places the latest quarter within a period described by management as one of expanding profitability and...

U-Haul Holding (UHAL) just received the Gold Stevie award from the American Business Awards for its U-Box Load Share program, highlighting the company’s sustainability efforts and potential relevance for long term investors. See our latest analysis for U-Haul Holding. The Gold Stevie award arrives at a time when U-Haul Holding’s share price is US$51.17, with a 1 month share price return of 8.2% contrasting with a 1 year total shareholder return decline of 18.4%, suggesting shorter term...

If you are wondering whether Sociedad Química y Minera de Chile still offers good value after its recent gains, or if you may be late to the story, this article focuses squarely on what the current price could mean for you. The stock finished the latest session at US$92.64, with returns of 3.6% over 7 days, 11.3% over 30 days, 32.9% year to date and 173.7% over the last year. These figures naturally raise questions about how much of the story is already reflected in the price. Recent news...

Northwest Bancshares (NWBI) has drawn fresh attention after its latest quarterly report, which paired higher commercial and industrial loan balances with tighter expense control, improved credit quality, and management’s emphasis on operational efficiency and deposit costs. See our latest analysis for Northwest Bancshares. At a share price of $14.03, Northwest Bancshares has paired a 17.11% year to date share price return with a 20.00% total shareholder return over one year and a 62.65% total...